| # | Drug | Count |
|---|---|---|
| 0 | PROPYLENE GLYCOL | 9 |
| 1 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 7 |
| 2 | PROPYLENE GLYCOL EMULSION | 6 |
| 3 | HUMAN RHO(D) IMMUNE GLOBULIN | 5 |
| 4 | ACETAMINOPHEN | 3 |
| 5 | ACETAMINOPHEN 500MG | 3 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 3 |
| 7 | INSULIN ASPART | 3 |
| 8 | ORAL SEMAGLUTIDE | 3 |
| 9 | PAIN RELIEVER | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE | 1 | 0.0435 |
| 1 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 7 | 0.0062 |
| 2 | HUMAN RHO(D) IMMUNE GLOBULIN | 5 | 0.0049 |
| 3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | 1 | 0.0004 |
| 4 | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | 1 | 0.0004 |
| 5 | GLYCERIN SUPPOSITORY | 1 | 0.0004 |
| 6 | GLYCERIN SUPPOSITORIES | 1 | 0.0004 |
| 7 | INSULIN ASPART INJECTION | 1 | 0.0004 |
| 8 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 9 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 1 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 2 | 0.0001 |
| 2 | Non-Standardized Plant Allergenic Extract [EPC] | 1 | 0.0001 |
| 3 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Non-Standardized Chemical Allergen [EPC] | 3 | 0.0000 |
| 5 | GLP-1 Receptor Agonist [EPC] | 6 | 0.0000 |
| 6 | Arteriolar Vasodilator [EPC] | 1 | 0.0000 |
| 7 | Non-Standardized Food Allergenic Extract [EPC] | 1 | 0.0000 |
| 8 | 5-alpha Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |